Drug Discoveries
through…
Machine Learning
At Black Arrow Biotech, we harness the power of machine learning to revolutionize peptide research and drug discovery.
What we do
We use proprietary Artificial Intelligence Tools (“JÜRI”) to rapidly accellerate the development of new peptide drugs for the treatment of cancer and other diseases.
How we do it
We generate and discover new molecules that can have the best outcome to combat disease safely and effectively.
Why we do it
Conventional Pharmacology can take 10-15 years to get from the lab to the patient. We want to close the gap using modern techniques such as AI, which will improve the more we keep applying it.
Who we do it for
The billions of people suffering from disease every single day.
Meet JÜRI
Your AI Peptide Discovery Partner
JÜRI is our leading-edge AI, designed to revolutionize peptide screening and generation. With advanced algorithms, it accelerates drug discovery by identifying potential therapeutic candidates more efficiently than ever.
Innovate
Unlocking the Future of Drug Discovery
At Black Arrow Biotech, we harness the power of machine learning to revolutionize peptide development. Our cutting-edge services, including Peptide Screening and comprehensive Peptide Libraries that are designed to address a wide range of diseases.
Peptide Screening
Precision Meets Innovation
Our Peptide Screening service utilizes advanced algorithms to identify and optimize peptides for targeted therapeutic applications.
Peptide Libraries
Wide Range of Customizations
Our Peptide Library offers a diverse range of peptides, providing researchers with the tools they need for effective drug discovery.
Democritus University of Thrace, Greece
Get In Touch
Discover how our AI technology can revolutionize peptide development and drug discovery for your needs.